Cargando…
SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Secretory leukocyte protease inhibitor (SLPI) has been reported to function as a regulatory factor in several cancers. However, its biological functions and underlying mechanisms in HCC remain to be uncovered. Here, we...
Autores principales: | Sun, Jie, Li, Jinfan, Wu, Zhen, Liang, Yuwan, Duan, Rong, Zheng, Mengsha, Wang, Jing, Kong, Derun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692157/ https://www.ncbi.nlm.nih.gov/pubmed/34975323 http://dx.doi.org/10.7150/ijbs.65676 |
Ejemplares similares
-
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress‐driven hepatocellular carcinoma progression
por: He, Lin, et al.
Publicado: (2023) -
Baicalein Induces Apoptosis and Autophagy via Endoplasmic Reticulum Stress in Hepatocellular Carcinoma Cells
por: Wang, Zhongxia, et al.
Publicado: (2014) -
How SLPI soothes
por: Van Epps, Heather L.
Publicado: (2005) -
Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis
por: Rong, Fengju, et al.
Publicado: (2018) -
Endoplasmic reticulum stress and apoptosis
por: Faitova, Jitka, et al.
Publicado: (2006)